Abuse of drugs is a worldwide problem. Drug addiction is increasing tremendously in the South Asian countries especially in Bangladesh where such addiction is widespread among the younger age groups. It causes rapid erosion of educational, cultural, moral and family values. On the basis of defined criteria a total of 300 drug abusers who undergoing detoxification at the outpatient department of Central Drug Addiction Treatment Centre, Tejgaon, Dhaka were selected. The study was done for a period of one year from July 2013 to June 2014. Data were collected by face to face interview using pre-tested questionnaire. The analysis was done by computer using SPSS version 22.0. About 68% of the drug abusers had taken drugs for 2-5 years and 38% had taken three drugs during their life time. The major influencing factor for taking drugs was for peer pressure. Among the drug abusers 77% had taken Ganja, 60% Heroin as their first drug and 37% Yaba as their last drug. The depression was measured by the Beck's Depression Inventory that showed 55% of the drug abusers had moderate depression, 23% borderline clinical depression, 15% mild mood disturbance, 4% severe depression, and 3% had extreme depression. There were s ignificant associations between the duration of taking drugs (p<0.001), the number of taking drugs (p<0.006), and the age of first use of drugs (p<0.019) with depression. Majority of the drug abusers had depression and a significant number of them were involved in antisocial activities as well as violence. Family and social participation, behavioral therapies and proper medical management are essential to control drug addiction.
Diabetes is a global health burden and threat that needs proper managements. Glycosylated hemoglobin (HbA1c) is an important marker, both in the diagnosis and treatment of diabetes. The purpose of the study was to demonstrate the influence of ethnicity on HbA1c in relation to fasting plasma glucose (FPG), by observation among newly diagnosed type 2 diabetics in Arab population, with a view to speculate comparison with other population groups in order to make a more rationale management plan of diabetes for different ethnic groups. This cross sectional study was performed amongst 573 newly diagnosed, untreated type 2 diabetic subjects attending the outpatient department (OPD) of Al-Qunfudah General Hospital Diabetic centre, in the Kingdom of Saudi Arabia (KSA) from June 2010 to April 2013. Data were collect by face to face interview using pre-tested questionnaire. Height, weight, body mass index (BMI), blood-pressure, fasting and post-prandial venous plasma glucose, HbA1c and serum creatinine were measured. Patients receiving any treatment for diabetes, suffering from Type 1 Diabetes Mellitus (T1DM), having ketonuria ?2+, pregnant and patients of hemolytic anemia were excluded from the study. Sensitivity, specificity and the area under the Receiver Operating Characteristic (ROC) Curve for HbA1c using different cut-off values were calculated using venous FPG considering gold standard. The analysis was done by computer using SPSS version 22.0. Mean fasting plasma glucose was 227.9±81.45mg/dl and mean HbA1c was 9.79±2.22%, 269 patients (47%) had HbA1c >10%, much above ?6.5%, cutoff determined by American Diabetic association (ADA). For diagnosing diabetes, the optional cut-off for HbA1c was 7.9%, with sensitivity of 83.6%, specificity of 87.8%, positive predictive value of 98.6%, and negative predictive value of 33.3%. These characterizations would not only accord to construct more tactical initiative for comparison but also instigate the rationale to individualize HbA1c on ethnic basis for diabetes management protocols.South East Asia Journal of Public Health Vol.6(2) 2016: 42-47
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.